NCT07181837 A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome Status RECRUITING Phase PHASE1/PHASE2
NCT07157254 A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS) Status RECRUITING Phase PHASE2
NCT07136454 Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome Status AVAILABLE Phase N/A
NCT06737718 Use of Eye Tracking to Study Social Perception Abnormalities in Children With Angelman Syndrome Status RECRUITING Phase N/A
NCT06617429 Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06415344 Long-term Extension of GTX-102 in Angelman Syndrome Status ENROLLING_BY_INVITATION Phase PHASE3
NCT06353620 Structural-functional Connectome in Drug-resistant Epilepsies and Neurodevelopmental Syndromes With Epilepsy Status RECRUITING Phase N/A
NCT06337383 Study of the Prevalence of Autistic Traits in Angelman Syndrome Status RECRUITING Phase N/A
NCT06139172 Web Intervention for Parents of Youth With Genetic Syndromes (WINGS) Status RECRUITING Phase NA
NCT05783791 Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome Status COMPLETED Phase N/A
NCT05637697 Angelman Syndrome Video Assessment (ASVA) Source Material Study Status COMPLETED Phase N/A
NCT05630066 A Study to Investigate the Pharmacokinetics (PK) and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. Status COMPLETED Phase PHASE2
NCT05127226 HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome Status RECRUITING Phase PHASE1/PHASE2